Health monitoring company Sonde Health as raised a $19.25 million Series B investment round.
The company has raised $35.25 million in total and will use the funding to support global commercial growth, deepen its respiratory and mental health monitoring technologies and build capabilities for additional health conditions.
Sonde Health CEO, David Liu, said:
“Digital biomarkers are becoming a mainstay in healthcare.
“Today’s healthcare companies are realizing how vocal biomarkers can engage people earlier in their health.
“The data and insights found in voice can power health monitoring and patient stratification so issues can become apparent well before a costly medical event occurs.
“With voice and any listening device, accessible and effective health monitoring can be made available to the majority of the world.”
Sonde’s health-labelled voice dataset includes over 1.2 million voice samples from over 85,000 subjects on four continents.
Sonde is the only vocal biomarker company to offer AI/machine learning-based monitoring products for multiple health conditions and is able to embed its technology into device chipsets for passive and safe health monitoring through voice.
The company provides its vocal biomarker technology to companies across several health verticals, including telehealth, pharmaceutical, remote patient monitoring and consumer/medical devices.
The round was led by Partners Investment, with its Vice President, Joonsoo Kim, set to join Sonde’s board of directors.
“Sonde is at the forefront of a vocal biomarker revolution that has the potential to change how we detect, manage, and understand our health.
“They have the deepest, high-quality dataset combined with leading edge-processing technology, which gives them a significant competitive advantage.
“We believe Sonde’s team and platform are primed to disrupt and add tremendous value to health monitoring around the world, and we’re thrilled to support the company’s mission to harness the power of voice for better health.”
AI helps cut nuisance alerts for healthcare teams
Stabilising the NHS – it’s going to take a lot more than AI
Answer Digital enables speedy deployment of AI with strategic partnerships
Transforming NHS procurement: How good data holds the key to integrated care
British tech firm gets green light on fibroids patent
Cancer leaders pen ‘letter to the world’ calling for urgent investment
Generative AI used to create translatable paediatric care videos for LMIC hospitals
NHS Forth Valley goes live with RCPCH GrowthAPI integrated with Morse Mobile EPR
Mid and South Essex ICS building new shared care record with Orion Health
Red light can reduce blood glucose levels, study finds
- Medtech3 weeks ago
Medtech leadership insights with Barry Warden
- Insight6 days ago
Neuromelanin imaging: A new path to brain health insights
- Digital health4 weeks ago
Assistance app helps blind and visually impaired commuters find bus stops
- Features2 weeks ago
Evidence generation: The key to opening up access to treatments for Sickle Cell patients